WHO Raises Concern Over Critical Shortage of Obesity Jabs
Fewer than one in 10 patients eligible to benefit from weight-loss injections such as Wegovy can access them, caution the global health agency as it releases its first recommendations on the medications.
Considering more than one billion people worldwide currently classified as obese, it is advocating for broader and more equitable availability to this class of drugs.
Per estimates, in excess of 2,000,000,000 are projected to be obese by 2030 without intervention.
"The latest guidance acknowledges that excess weight is a long-term condition that can be treated with comprehensive and continuous treatment," said WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and logistical bottlenecks are significant hurdles to universal availability to the treatments that can assist patients in reducing significant body mass, notes the body.
GLP-1 Therapy Shortage
Despite the present best projected case, the manufacturing of these medications might only reach around 100 million people – fewer than 10% of eligible patients, according to the health organization.
The recommendation calls on countries and companies to increase availability, via approaches like patent sharing.
The intellectual property rights on the active ingredient – the primary ingredient of a leading brand – is scheduled to end in a number of nations in 2026.
The Way Weight-Loss Jabs Function
These medications replicate a biological compound to slow digestion, curb appetite and increase satiety so people consume fewer calories.
People typically start to lose weight in the initial weeks of starting on the regular doses.
Studies points to users may see weight return after a year of halting the drug, as their typical food cravings resume.
To be above a healthy weight raises your likelihood for contracting health problems, including type 2 diabetes, cardiovascular issues, stroke, and certain cancers.
Excess weight affects people in all nations and was associated with millions of fatalities worldwide in 2024, as per the health agency.
